Physician profile
Tolan A Le
NPI 1407869639
$657.92
in general payments reported to CMS, 2019-2025
11 companies · $63.05 in 2025
The $63.05 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.46 · 2020: $20.85 · 2021: $118 · 2022: $175 · 2023: $140 · 2024: $99.72 · 2025: $63.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $302.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $219.91 | 2021-2022 | |
| Dexcom, INC. | $108.37 | 2022-2024 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $77.33 | 2023-2025 | Bexsero, Pediarix, Arexvy |
| Merck Sharp & Dohme LLC | $69.73 | 2021-2024 | Gardasil 9, Vaxneuvance, Vaxelis |
| Hologic Sales and Service, LLC | $41.46 | 2019 | |
| Novo Nordisk INC | $38.63 | 2023-2024 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $22.83 | 2022 | |
| Pfizer INC. | $21.92 | 2024 | |
| Alkermes, INC. | $20.85 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.17 | 2025 | Jardiance |
| Cranial Technologies, INC | $17.72 | 2025 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tolan Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.